A3323512
                    D(-)-Norgestrel , ≥99% , 797-63-7
                            Synonym(s):
Levonorgestrel;D (?)-Norgestrel;13β-Ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one;17α-Ethynyl-18-homo-19-nor-testosterone;18,19-Dinor-13β-ethyl-17β-hydroxy-4-pregnen-20-yn-3-one
                            
                        
                CAS NO.:797-63-7
Empirical Formula: C21H28O2
Molecular Weight: 312.45
MDL number: MFCD06198806
EINECS: 212-349-8
| Pack Size | Price | Stock | Quantity | 
| 50MG | RMB39.20 | In Stock | 
                                                 | 
                                        
| 250mg | RMB127.20 | In Stock | 
                                                 | 
                                        
| 1g | RMB356.80 | In Stock | 
                                                 | 
                                        
| 5g | RMB759.20 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
Update time: 2022-07-08
                    PRODUCT Properties
| Melting point: | 206°C | 
                                    
| alpha | D20 -32.4° (c = 0.496 in CHCl3) | 
                                    
| Boiling point: | 392.36°C (rough estimate) | 
                                    
| Density | 1.0697 (rough estimate) | 
                                    
| refractive index | 1.4900 (estimate) | 
                                    
| storage temp. | Sealed in dry,2-8°C | 
                                    
| solubility | Practically insoluble in water, sparingly soluble in methylene chloride, slightly soluble in ethanol (96 per cent). | 
                                    
| form | Solid | 
                                    
| pka | 13.09±0.40(Predicted) | 
                                    
| color | Crystals from MeOH/CHCl3 | 
                                    
| optical activity | [α]/D -28 to -36° (C= 1.0g/100 ml in CDCl3) | 
                                    
| Water Solubility | 10mg/L(temperature not stated) | 
                                    
| Merck | 13,6736 | 
                                    
| BCS Class | 	1 | 
                                    
| InChI | InChI=1/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/s3 | 
                                    
| InChIKey | WWYNJERNGUHSAO-HABXDNTMNA-N | 
                                    
| SMILES | C([C@]12CC[C@]3([H])[C@@]4([H])CCC(=O)C=C4CC[C@@]3([H])[C@]1([H])CC[C@@]2(O)C#C)C |&1:1,4,6,16,18,22,r| | 
                                    
| CAS DataBase Reference | 797-63-7(CAS DataBase Reference) | 
                                    
Description and Uses
Levonorgestrel exhibits some androgenic activity but no glucocortic oid or antimineraloc orticoid action. Levonorgestrel can be administered orally, transdermally (combined with estradiol and formulated as a 7-day patch), and for prolonged, continuous use, via an intrauterine device (IUD). The oral bioavailability of levonorgestrel is approximately 95%. From a protein binding pers pective, 48% of an oral dose is bound to SHBG, and 50% is bound to albumin. Levonorgestrel under goes metabolic reduction of its ketone and is hydroxylated.
progestin
Safety
| Symbol(GHS) | ![]() GHS08  | 
                                    
| Signal word | Danger | 
| Hazard statements | H351-H360D-H362 | 
| Precautionary statements | P202-P260-P263-P264-P270-P308+P313 | 
| Hazard Codes | Xn,T | 
| Risk Statements | 20/21/22-40-60 | 
| Safety Statements | 22-36 | 
| WGK Germany | 3 | 
| RTECS | JF8225000 | 
| HS Code | 2937230000 | 
| Hazardous Substances Data | 797-63-7(Hazardous Substances Data) | 







